Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026

Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026.

Eli Lilly's executive comments indicate that pricing pressures will likely constrain growth to the low to mid-teens through 2026. This suggests potential challenges in maintaining margins, which could impact investor sentiment and the stock's performance in the near term. Watch for how this narrative might affect broader sector valuations and peers in the pharmaceuticals space.